Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam Against Carbapenem-resistantEnterobacteriaceaein an in Vitro Hollow Fiber Model

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01969-17

Related search